SNTI Senti Biosciences Inc
Company Analysis
Latest News
🔴 Senti Biosciences is trading 5% down today after broader risk-off trading pressured biotech stocks
Senti Biosciences is trading 5.1% down now at $0.35 after broader risk-off trading pressured biotechnology and growth stocks on September 1, 2026. - The XBI...
🟢 Senti Biosciences is trading 9.43% up in pre-market — no clear catalyst identified
Senti Biosciences is trading 9.43% up at $0.41; no clear company-specific announcement was identified for September 1, 2026. - The latest major event was the...
🔴 Senti Biosciences is trading 8.6% down today; catalyst remains unclear
Senti Biosciences is trading 8.6% down at $0.37, with today’s specific catalyst unclear. - No new company-specific announcement or filing dated August 27,...
🟢 Senti Biosciences rises 5.6% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 Senti Biosciences is trading 5.74% up in pre-market as Nasdaq Composite gains 0.84%
Senti Biosciences is trading 5.74% up at $0.40 in pre-market after no clear company-specific catalyst was identified for August 25, 2026. - The move follows a...
🔴 Senti Biosciences is trading 7.38% down today in after-hours trading — No clear company-specific catalyst identified
Senti Biosciences is trading 7.38% down at $0.35 after no clear company-specific catalyst was identified for August 24, 2026. - Latest results, released...
🔴 Senti Biosciences is trading 12.45% down today as immediate cause remains uncertain
Senti Biosciences is trading at $0.34, down 12.45%, as the immediate cause of the August 24 decline remains uncertain. - Closed at $0.39 on August 21, 2026;...
🔴 Senti Biosciences is trading 8.65% down today in pre-market — no new catalyst identified
Senti Biosciences is trading 8.65% down at $0.35 after closing at $0.39 on August 21, 2026, with no new company-specific announcement identified to explain the...
🔴 Senti Biosciences is trading 10.53% down today with no company-specific announcement identified
Senti Biosciences is trading 10.53% down at $0.39 after falling from its August 20, 2026 close of $0.44; available coverage attributes the decline to...
🔴 Senti Biosciences is trading 5.44% down today amid sector-driven biotech weakness
Senti Biosciences is trading 5.44% down now at $0.41, amid sector-driven biotech weakness. - It fell 5.83% to $0.44 on August 20. - No new company-specific...
🟢 Senti Biosciences is trading 10.09% up in pre-market after a sector-driven biotech recovery
Senti Biosciences is trading 10.09% up at $0.48 in pre-market after recovering from the August 20, 2026 regular-session decline, with the move appearing...
🟢 Senti Biosciences is trading 6.65% up in after-hours trading after a sector-driven recovery
Senti Biosciences is trading 6.65% up now at $0.47 after recovering from its 5.83% regular-session decline to $0.44 on August 20, 2026; the move appears...
🔴 Senti Biosciences falls 5.3% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Senti Biosciences is trading 6.4% up in pre-market after positive Moderna-Merck Phase 3 melanoma-vaccine results
Senti Biosciences is trading 6.4% up now at $0.49 after biotechnology shares rallied following positive Phase 3 melanoma-vaccine results from Moderna and...
🟢 Senti Biosciences is trading 8.81% up today after positive Moderna-Merck cancer-vaccine results
Senti Biosciences is trading 8.81% up at $0.47 after biotech stocks rallied broadly on positive Moderna-Merck Phase 3 personalized cancer-vaccine results. -...
🟢 Senti Biosciences is trading 7% up in pre-market ahead of August 20 Q2 2026 earnings discussion
Senti Biosciences is trading 6.95% up at $0.46, with no clearly reported company-specific overnight catalyst identified for August 19, 2026. - Investor...
Senti Biosciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 20, 2026
Senti Biosciences (SNTI) is projected to report a Q2 2026 loss of $0.33 per share on revenue of approximately $0.015 million, with the stock trading near $0.45...
🟢 Senti Biosciences is trading 7% up in pre-market ahead of proposed merger vote and Q2 earnings announcement
Senti Biosciences is trading 6.98% up at $0.46 in pre-market ahead of its virtual annual shareholder meeting today, August 18, 2026, which includes a proposed...
Senti Biosciences Burns Through Its Cash Cushion — Can a Sub-Dollar Biotech Survive Past Year-End?
Shares of Senti Biosciences slid 10.4% to $0.40 on August 14 after the gene-circuit cell therapy company posted second-quarter results that were worse than...
🔴 Senti Biosciences is trading 10.4% down today after second-quarter adjusted EPS missed estimates
Senti Biosciences is trading 10.4% down now at $0.40 after second-quarter adjusted EPS of -$0.42 missed the -$0.26 estimate. - The company reported a $12.75...